No evidence of automatic atrial overdrive pacing efficacy on reduction of paroxysmal atrial fibrillation

W. de Voogt(Sint Lucas Andreas Hospital), N. van Hemel(Utrecht University), P. De Vusser, Georges H. Mairesse(Cliniques du Sud Luxembourg), R. van Mechelen(Sint Franciscus Gasthuis), Juhani Koı̈stinen(Turku University Hospital), A. van den Bos(Amphia Ziekenhuis), I. Roose, Jüri Voitk(North Estonia Medical Centre), Sinikka Yli‐Mäyry(Tampere University Hospital), Dirk Stockman(ZNA Middelheim Hospital), Dia El Allaf(Centre Hospitalier Régional de Huy), Hung‐Fat Tse(Queen Mary Hospital), Chu‐Pak Lau(Queen Mary Hospital)
EP Europace
July 17, 2007
Cited by 28Open Access
Full Text

Abstract

AIMS: Paroxysmal atrial fibrillation (PAF) is frequently encountered in pacemaker patients, most commonly in sick sinus syndrome. The combination of site-specific pacing in conjunction with an overdrive algorithm combined with antiarrhythmic drugs on the incidence of PAF in patients with a conventional indication for pacing is unknown. METHODS AND RESULTS: Patients with pacemaker indication and PAF received a DDDR-pacemaker, which included an automatic atrial overdrive (AO) algorithm. The atrial lead was implanted in either the right atrial appendage (RAA) (n = 83) or the right low-atrial septum (LAS) (n = 94). The algorithm was switched on or off in a 3 month, single blind crossover design and antiarrhythmic drugs were kept stable. A control group of 96 patients (LAS, n = 14; RAA, n = 84) without PAF served as controls to assess any proarrhythmic effect of overdrive pacing. Atrial fibrillation (AF) burden defined as cumulative time in mode switch was not reduced during automatic AO from either the RAA or from the LAS. The reduction was not effective both for AF of short (<24 h) and long (> or =24 h) duration. There was no atrial proarrhythmia induced by the overdrive algorithm in the control group. CONCLUSIONS: We could not demonstrate a reduction of AF burden defined as cumulative time in AF by the AO algorithm, in patients who are paced for standard indications and PAF, neither from the RAA nor from the LAS.


Related Papers

No related papers found

Powered by citation graph analysis